Burnham Drugs

Burnham Drugs is a health care, medical devices, and pharmaceutical startup founded in 1902 and based in the United States. The company's slogan emphasizes their commitment to providing comprehensive, high-tech at-home patient care, delivering expertly prepared medications and essential medical equipment right to the patient's doorstep. The startup's core focus lies in offering specialized services such as compounding, vital care, and medication-on-time programs. Burnham Drugs aims to provide a comprehensive program featuring IV drug therapy, parenteral nutrition, and enteral nutrition, facilitating complete in-home patient care. All solutions, medications, and nutrients are meticulously prepared by their pharmacists based on physician orders. Their Vital Care service includes either infusion suites or convenient home delivery of all necessary medications, solutions, pumps, poles, equipment, and supplies. Burnham Drugs collaborates with home health care agencies, nursing homes, and DME companies to ensure top-quality home-based pharmacy services. The company's efforts align with the growing demand for at-home medical care and the emphasis on patient comfort and convenience. As of now, specific information regarding the last investment amount and the last investment investors is not available. However, the startup's unique positioning in the healthcare industry, catering to the evolving needs of patients for at-home care, makes it an intriguing prospect for potential investors. Considering the increasing focus on personalized healthcare solutions and at-home patient care, Burnham Drugs holds promise as an investment opportunity in the healthcare sector.